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Conclusions: In our experimental conditions, the capability to induce
chondrogenic differentiation depends on the culture conditions used. The
transcription factor that actuates better in normoxic condition differs from
the one that displays a better action in a hypoxic atmosphere.
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GENE EXPRESSION CHANGES ASSOCIATEDWITH CHONDROGENIC
DIFFERENTIATION OF HUMANMSCS
J.F. Welter, L.A. Solchaga, K.J. Penick, P. Leahy, A.I. Caplan, V.M. Goldberg
Case Western Reserve Univ., Cleveland, OH
Purpose: Human mesenchymal stem cells (hMSCs) are useful for cartilage
tissue engineering as they can differentiate into chondrocyte-like cells
under conditions including high cell density and a deﬁned medium. Carti-
lage markers become detectable at the RNA and protein levels within the
ﬁrst week of differentiation. The phenotypic changes are the result of a
reprogramming of the gene expression and physiology of MSCs. To support
our studies of chondrogenic MSC differentiation, we used gene expression
microarrays to understand the sequence and extent of these changes.
Methods: Five hMSC preparations were derived from bone marrow aspi-
rates obtained under an IRB-approved protocol. The cells were expanded
through the end of ﬁrst passage in DMEM with serum and 10 ng/ml
FGF-2, then moved to aggregate culture in chondrogenic medium to
induce differentiation. Total RNA was extracted from 20 aggregates per
prep at days 0, 1, 3, 5, and 7; 5-8 μg of RNA were reverse-transcribed.
The three best cDNA preps were analyzed using Affymetrix U133A 2.0
microarrays. Spiked bacterial IVT were used as hybridization controls. Raw
data generated using GCOS software were scaled to 500 and imported into
Agilent GeneSpring 6.4. A short list of interesting genes was generated
by binary comparisons at each time point using MAS5.0 algorithms in
GCOS. Transcripts consistently called as increased or decreased in all three
preparations with an average absolute fold change ≥ 2.0 were included.
For genes referenced by multiple probesets, consistency checks were per-
formed, and we used the median value of the probesets. Filtered data were
then analyzed using GeneSpring, Ariadne Genomics Pathway Studio and
Partek Genomics Suite. Cluster analysis and principal component analysis
were performed on the ﬁltered data. A 3 × 3 array of self-organizing maps
(SOM) was created, and regulation pattern detection was performed; ﬁnally
assignment to speciﬁc cellular pathways attempted. We also mined the
database for chondrogenesis-related genes known to be modulated during
MSC differentiation from our experiments or from published reports.
Results: All arrays passed internal quality control. After ﬁltering the data,
we found a high-value population of 3,285 differentially expressed genes.
Cluster and SOM analysis revealed that most of the changes occurred be-
tween days 0 and 1 (1,723) or 2, with fewer changes occurring later. Small
subsets spiked or plummeted transiently on day one, even smaller subsets
showed steady in- or decreases over the study period. Pathway assignment
performed on the SOM groups suggests that genes regulating transcription,
cell-cycle, cell adhesion, and differentiation are highly regulated (both up
and down) beginning at the earliest time points.
Conclusions: We have a stringent database of gene expression changes
during early chondrogenic differentiation of hMSCs. Pattern analyses in-
dicate that most changes occur within the ﬁrst day and are permanent;
this suggests genes turned on or off during differentiation that are, thus,
MSC- or chondrocyte-speciﬁc. A much smaller set was transient, suggesting
involvement in gene expression regulation and lineage commitment. The
number of regulated genes affecting transcription, cell-cycle, cell adhesion,
and differentiation reﬂects the signiﬁcant reprogramming of the cells in the
transition from proliferation to differentiation. The database will be a use-
ful tool for interpreting molecular changes associated with chondrogenic
differentiation of MSCs.
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EFFECT OF FIBRONECTIN SPLICING ON CELL PROLIFERATION AND
CHONDROCYTE-SPECIFIC GENE EXPRESSION IN A MESENCHYMAL STEM
CELL SYSTEM
S.A. Jami, N.B. Sepulveda, J.H. Peters
UC Davis, Sacramento, CA
Purpose: During embryonic development, expression of ﬁbronectins (FNs)
bearing the alternatively spliced EIIIA and V segments is prevalent in
prechondrogenic mesenchymal cell condensations. However, expression of
these FNs becomes restricted near the time of chondrogenesis, suggesting
that they may not be compatible with processes by which mesenchymal
stem cells (MSCs) differentiate to chondrocytes.
Methods: We tested the effects of the EIIIA and V segments, expressed as
glutathione S-transferase (GST) fusion proteins, adsorbed to plastic or in
solution, on proliferation and gene expression in rat RCJ 3.1 multipotential
mesenchymal cells, an MSC model cell line, using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and real-time PCR. A
GST fusion protein containing the 10th type III repeat of FN (III-10) and
poly-L-lysine (PLL) were also tested.
Results: In 15% fetal bovine serum (FBS), cells grown in monolayer for 7
days (d) on surfaces coated with EIIIA, V, III-10, or PLL appeared conﬂuent,
and attained similar MTT scores, with OD570-630 values (average±S.D.)
of 1.3±0.8, 1.4±0.8, 1.3±0.7, and 1.5±1.0, respectively (ns, N=3). Under
serum-free conditions, more cells remained adherent to surfaces coated
with III-10 than the other 3 agents after 7 d in HEScGRO (Millipore),
with respective values of 0.2±0.1**, 0.2±0.1**, 0.6±0.2, and 0.4±0.2*. In
KnockoutSR (GIBCO), V and III-10 both promoted greater retention of
adherent cells than EIIIA and PLL, with respective values for the 4 agents
of 0.2±0.0***, 0.6±0.1, 0.7±0.1, and 0.3±0.1**. Aggrecan expression in cells
grown in 15% FBS for 7 d on each of the substrates decreased compared
to cells grown for 1 d on III-10, but not signiﬁcantly so (fold changes of
-1.0±0.7, -0.7±0.6, -2.8±0.1, and -2.6±0.3, respectively) (N=3). In contrast,
aggrecan expression increased in cells grown in pellet culture in the pres-
ence of TGF-b, with a fold change of 2.5±1.0 at 14 d compared to cells at
0 d (ns, N=3). Addition of soluble EIIIA (200 nM) to such cultures triggered
reduced aggrecan expression so that the fold change at 14 d compared to 0
d cells was -7.1±0.1 (18.6-fold reduction compared to untreated cells, ***,
N=3). p>0.05=ns, p<0.05=* o<0.01=***, p<0.001=***
Conclusions: The 10th type III repeat and V segment of FN promote
anchorage-dependent proliferation/survival of RCJ 3.1 MSCs in serum-free
culture. These cells lose aggrecan expression in monolayer culture, and this
is not appreciably affected by apposition to EIIIA, V, or III-10. In contrast,
aggrecan expression increases during pellet culture, and such acquisition of
chondrocyte-speciﬁc gene expression is inhibited by soluble EIIIA, suggest-
ing that this FN segment could potentially constitute a therapeutic target
in efforts to promote chondrocytic differentiation of MSCs, or to reverse
cartilage degeneration in osteoarthritis. Research funded by a VA Merit
grant.
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SEQUENTIALLY PROGRAMMEDMAGNETIC FIELD THERAPY AS AN
EFFECTIVE TREATMENT FOR OSTEOARTHRITIS
V.G. Vasishta Sr.
Former Prof and HOD, Inst. of Aerospace Med., Indian Air Force, Bangalore,
India
Introduction and Purpose: Different modalities of available treatment for
treating osteoarthritis, including newer drugs like NSAIDS, Intra-articular
injections, etc have been tried with very little or no success, leaving
patients with the only surgical option of joint replacement. All of these
except surgery provide only symptomatic relief and do not reverse the
continuous damage done to the cartilage. The newer drugs also come
withmany undesirable side effects. Total knee replacement Surgery (TKR) is
often beyond the ﬁnancial reach of many patients, especially in developing
countries. Even TKR surgery has a severe painful recovery period and a low
patient acceptance. So there has always been a need for a safe treatment
method which would be pain free and also reverse the disease process.
Sequentially Programmed Magnetic Field (SPMF) Therapy utilizes Magnetic
Field Generators (MFG) that can be precisely controlled and focused onto
the affected tissues. The normal physiological remodeling of cartilage oc-
curs due to piezoelectric stimuli which are lost in osteoarthritic patients.
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By utilizing speciﬁc frequencies in the range of 6-30Hz based on tissue
type and grade of osteoarthritis this stimulus is recreated by SPMF therapy
leading to cartilage regeneration.
This recreated peizoelectric stimuli, is known to enhance mitosis and
cell regeneration by normalizing the abberant electromagnetic ﬁelds of
microtubules of the centrioles
Methods: 195 patients with bilateral osteoarthritis (OA) of knees were
assessed by internationally recognized Knee Society clinical rating system;
the scores computed prior to treatment, after 21 days of therapy, at 3 and
9 months. In addition, MRI of the treated knees was done using standard
protocol, before treatment, at three and nine months after treatment, to
measure objective changes in cartilage thickness.
Results: This non-randomized, phase II study showed statistically highly
signiﬁcant improvement in pain scores, total knee scores, total functional
scores and the range of motion, immediately after the treatment vis-à-vis
pre-treatment values, and this improvement persisted when re-evaluated
at three and nine months. There was also a signiﬁcant increase in cartilage
thickness at three months and nine months from 0.64mm (±0.02) baseline
to 0.88 mm (±0.07) in left knee, and 0.65mm (±0.02) to 0.89mm (±0.05)
in the right knee joint (p<0.001) at 3 months and to 1.26mm (±0.02mm)
in the left knee and 1.23mm (±0.03mm) in the right knee at the end of 9
months.
Conclusions: Therapeutic exposure to SPMF therapy is effective in ame-
liorating the signs and symptoms of OA, and inducing regeneration of
chondrocytes as evidenced by increase in cartilage thickness. SPMF therapy
is an effective treatment modality for osteoarthritis.
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EXPANSION AND CHONDROGENIC DIFFERENTIATION OF HUMAN BONE
MARROW-DERIVED MESENCHYMAL STEM CELLS FOLLOWING
RAAV-MEDIATED GENE TRANSFER AND OVEREXPRESSION OF HUMAN
FGF-2
H. Madry, D. Kohn, M. Cucchiarini
Inst. for Experimental Orthopaedics, Homburg/Saar, Germany
Purpose: Articular cartilage lesions are an important problem in or-
thopaedic surgery. The use of progenitor cells such as bone marrow-derived
mesenchymal stem cells (MSCs), as platforms to deliver candidate genes
in a suitable conformation is an attractive approach to enhance cartilage
repair. Here, we tested the ability of rAAV vectors to overexpress FGF-2
that promotes the expansion and differentiation of human MSCs in a
three-dimensional environment.
Methods: rAAV were packaged, puriﬁed, and titrated as previously de-
scribed. All transgene cassettes were controlled by the CMV-IE pro-
moter/enhancer: E. coli beta-galactosidase (rAAV-lacZ), Red Fluorescent
Protein (rAAV-RFP), Fireﬂy luciferase (rAAV-luc), and a human basic ﬁbrob-
last growth factor (hFGF-2) cDNA (rAAV-hFGF-2). Bone marrow aspirates
were obtained from the iliac crest of donors. Aspirates were layered onto
Histopaque-1077 density gradient and the nucleated cell fraction was
collected and resuspended in hMSC culture medium containing stimulatory
supplements (StemCell Technologies Inc.). Cells were transduced with rAAV
for up to 21 days in monolayer or in aggregate cultures (2×105 cells). Ag-
gregates were kept in DMEM high glucose, ITS+ Premix, pyruvate, ascorbate
2-phosphate, dexamethasone, and TGF-β. Transgene expression was deter-
mined by X-Gal staining, live ﬂuorescence, luciferase assay, FGF-2 ELISA,
and by immunocyto- and immunohistochemistry. Paraﬃn-embedded sec-
tions of aggregates (5 μm) were stained with toluidine blue and alizarin
red. Indirect immunostaining was also performed to detect type-II and
type-X collagen, Runx-2, and Sox9. The DNA contents were monitored by
ﬂuorimetric assay, the proteoglycan contents by binding to DMMB, and
the type-II collagen contents by ELISA. Morphometric measurements were
performed at 3 standardized sites by image analysis. Each condition was
performed in triplicate in 2 independent experiments. Data are expressed
as mean ± SD. The t-test was employed with P<0.05 considered statistically
signiﬁcant.
Results: Sustained, dose-dependent transgene expression was observed in
monolayer cultures of hMSCs, with FGF-2 levels being from 350.2±2.5 to
41.1±1.2 pg/ml/24 h over time in rAAV-hFGF-2-transduced cells vis a vis
rAAV-lacZ (< 0.01 pg/ml/24 h). Luciferase activity was of 16.3±0.6 RLU/mg
total proteins after 21 days in rAAV-luc-transduced cells compared with
rAAV-lacZ (0.2±0.1 RLU/mg total proteins). Eﬃcient, sustained transgene
expression was also seen in aggregates (Fig. 1), with FGF-2 levels from
375.1±1.6 to 136.1±1.4 pg/ml/24 h over time in rAAV-hFGF-2 aggregates
Figure 1. Transgene expression in hMSCs aggregates (day 21).
Figure 2. Toluidine blue staining and detection of type-II collagen in hMSCs aggregates
(day 21).
vis a vis rAAV-lacZ (1.51±0.4 pg/ml/24 h). Chondrogenic differentiation of
cells was observed after 21 days in all types of aggregates (Fig. 2). Sox9
immunoreactivity was visible, whereas that for type-X collagen and Runx-2
and alizarin red staining were less intense. The diameters (856±30 versus
538±36 μm), DNA contents (1.039±0.005 versus 0.942±0.009 ng/mg total
proteins), and cell numbers (862±14 versus 435±12 cells/mm2) of the FGF-
2 aggregates were signiﬁcantly higher than those of the lacZ aggregates
(1.6-fold, 1.2-fold, and 1.9-fold, respectively; always P<0.001). In con-
trast, there was no difference in the proteoglycan contents (0.80±0.10 vs.
0.77±0.05 ng/mg total proteins) and type-II collagen contents (0.023±0.005
vs. 0.020±0.010 ng/mg total proteins) between both types of aggregates
(always P=1).
Conclusions: The data show that FGF-2 can be overexpressed in MSCs
via rAAV, promoting expansion and differentiation in a three-dimensional
environment, suggesting that gene modiﬁcation of MSCs via rAAV may ﬁna
application to treat articular cartilage lesions.
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CUMULATIVE EFFECT OF MECHANICAL STIMULUS ON CHONDROGENESIS
OF HYMAN MESENCHYMAL STEM CELL IN SCAFFOLDS USED FOR
CARTILAGE REPAIR
Z. Luo, M. Pullan, J. Hudson, R. Shore, B. Seedhom
Univ. of Leeds, Leeds, United Kingdom
Purpose: The aim of the study is to better understand the induction and
remodelling of cartilage-like tissue in non-woven ﬁlamentous scaffolds
intended for cartilage repair. The two objectives were to: 1) investigate the
effect of cumulative mechanical stimulus on cell proliferation, morphology
and metabolic activity in human bone marrow mesenchymal stem cells
(BMMSCs). These cells were seeded onto non-woven pads of biomaterial
and pulsatile hydrostatic pressure (PHP) applied incrementally over a 10
week period in a manner that simulates the loading conditions occurring at
a cartilage repair site after the implantation of scaffolds for cartilage repair,
and 2) thereby obtain an optimal post-operative rehabilitation regime
following joint implant surgery.
Methods: Human BMMSCs (Lonza) from 3 donors were seeded onto
226 plasma treated polyester scaffolds (PTPS) at 2.5×105 cells/scaffold
and divided into 2 groups; group one being subjected to PHP, group
two remained unloaded and acted as control. In group one, cell-seeded
